References
1. Ballreich JM, Gross CP, Powe NR, et al. Allocation of National
Institutes of Health Funding by Disease Category in 2008 and 2019. JAMA
Network Open 2021;4:e2034890-e2034890.
2. Kobayashi T, Hibi T. Improving IBD outcomes in the era of many
treatment options. Nature Reviews Gastroenterology & Hepatology
2023;20:79-80.
3. Manns MP, Maasoumy B. Breakthroughs in hepatitis C research: from
discovery to cure. Nature Reviews Gastroenterology & Hepatology
2022;19:533-550.
4. Ying X, Rosenblatt R, Fortune BE. Trends in Industry Payments to
Gastroenterologists and Hepatologists in the United States From 2014 to
2020. Gastroenterology 2022;163:787-791.
5. Murayama A, Kugo H, Saito Y, et al. A Nine-year Investigation of
Healthcare Industry Payments to Pulmonologists in the United States. Ann
Am Thorac Soc 2023.
6. Murayama A, Hirota S. Industry payments to pathologists in the USA
between 2013 and 2021. J Clin Pathol 2023.
7. Murayama A, Kamamoto S, Kugo H, et al. Research and Non-research
Industry Payments to Nephrologists in the United States between 2014 and
2021 (in press). Journal of the American Society of Nephrology 2023.
8. Vanood A, Sharrak A, Karabon P, et al. Industry-Sponsored Research
Payments in Neurosurgery-Analysis of the Open Payments Database From
2014 to 2018. Neurosurgery 2021;88:E250-e258.
9. Sharrak A, Nguyen T, Karabon P. Industry Research Payments to
Urologists: The First 5 Years of Open Payments Research Data. J Urol
2020;204:408-410.
10. Kalva P, Kakkilaya A, Mekala P, et al. Trends and Characteristics of
Industry Payments for Ophthalmology Research From 2014 to 2020. JAMA
Ophthalmol 2022;140:1105-9.
11. Murayama A, Kamamoto S, Kawashima M, et al. Cross-sectional analysis
of pharmaceutical payments to Japanese board-certified
gastroenterologists between 2016 and 2019. BMJ Open 2023;13:e068237.
12. Scher JU, Schett G. Key opinion leaders - a critical perspective.
Nat Rev Rheumatol 2021;17:119-124.
13. Ahn R, Woodbridge A, Abraham A, et al. Financial ties of principal
investigators and randomized controlled trial outcomes: cross sectional
study. BMJ 2017;356:i6770.
Table 1. Industry-sponsored grand, direct research and associated
research payments between 2014 and 2021